Certara acquires applied biomath expanding its biosimulation portfolio to industrialize new capabilities for optimal dosing for novel therapies

Princeton, n.j., dec. 13, 2023 (globe newswire) -- certara, inc. (nasdaq: cert) today announced it has acquired applied biomath, an industry-leader in providing model-informed drug discovery and development support to help accelerate and de-risk therapeutic research and development (r&d).
CERT Ratings Summary
CERT Quant Ranking